Search Results
One month DAPT is “becoming standard of care” for high bleeding risk patients following PCI
MASTER DAPT: dual antiplatelet therapy after coronary stenting in high bleeding risk patients
Optimizing DAPT in Complex & High Bleeding Risk Patients
Journal Club - Dual Antiplatelet therapy after PCI in Patients at High Bleeding Risk (MASTER DAPT)
One month dual antiplatelet therapy non inferior to standard regimens- MASTER DAPT TRIAL
What you need to know about DAPT in high-bleeding risk patients - GulfPCR-GIM 2020
Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk
MASTER DAPT trial: dual antiplatelet therapy after coronary stenting - AICT-AsiaPCR 2021
Short DAPT in high bleeding risk: ready for prime time? - EuroPCR 2021
Short Duration DAPT and DAPT De-Escalation: The New Era of DAPT Post-PCI
Evidence counts: Latest data from Onyx One-month DAPT program & Renal Denervation – GulfPCR-GIM 2020
Benefits and Risks of Extended DAPT after DES
